Michael J. Ravitz

487 total citations
7 papers, 407 citations indexed

About

Michael J. Ravitz is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Michael J. Ravitz has authored 7 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Physiology. Recurrent topics in Michael J. Ravitz's work include Cancer-related Molecular Pathways (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Tuberous Sclerosis Complex Research (2 papers). Michael J. Ravitz is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Tuberous Sclerosis Complex Research (2 papers). Michael J. Ravitz collaborates with scholars based in United States. Michael J. Ravitz's co-authors include Charles E. Wenner, Emmett V. Schmidt, Mary C. Lynch, Li Chen, Michael J. Pazin, Kevin Korenblat, Alan J. Kinniburgh, Calogero Dolce and Tae‐Aug Kim and has published in prestigious journals such as Molecular and Cellular Biology, Cancer Research and Journal of Cellular Physiology.

In The Last Decade

Michael J. Ravitz

7 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Ravitz United States 7 321 143 62 32 27 7 407
Mariya Yakymovych Sweden 9 334 1.0× 96 0.7× 69 1.1× 41 1.3× 26 1.0× 10 420
V Ellenrieder Germany 2 262 0.8× 215 1.5× 67 1.1× 30 0.9× 35 1.3× 2 365
Åsa Franzén Sweden 6 241 0.8× 118 0.8× 38 0.6× 19 0.6× 27 1.0× 7 340
Özge Alper United States 9 200 0.6× 180 1.3× 41 0.7× 41 1.3× 29 1.1× 12 365
Marie-Thérèse Webster United Kingdom 5 295 0.9× 82 0.6× 32 0.5× 41 1.3× 34 1.3× 7 377
Dao Doan United States 7 250 0.8× 179 1.3× 67 1.1× 36 1.1× 34 1.3× 11 437
Anni Laine Finland 5 274 0.9× 178 1.2× 60 1.0× 19 0.6× 29 1.1× 6 392
Yumiko Shinohe Japan 9 166 0.5× 168 1.2× 72 1.2× 22 0.7× 24 0.9× 11 336
Roma H. Patel United States 11 470 1.5× 138 1.0× 99 1.6× 39 1.2× 18 0.7× 16 582
Tracy L. Krebs United States 6 267 0.8× 110 0.8× 58 0.9× 33 1.0× 35 1.3× 10 364

Countries citing papers authored by Michael J. Ravitz

Since Specialization
Citations

This map shows the geographic impact of Michael J. Ravitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Ravitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Ravitz more than expected).

Fields of papers citing papers by Michael J. Ravitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Ravitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Ravitz. The network helps show where Michael J. Ravitz may publish in the future.

Co-authorship network of co-authors of Michael J. Ravitz

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Ravitz. A scholar is included among the top collaborators of Michael J. Ravitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Ravitz. Michael J. Ravitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Schmidt, Emmett V., Michael J. Ravitz, Li Chen, & Mary C. Lynch. (2009). Growth controls connect: Interactions between c-myc and the tuberous sclerosis complex-mTOR pathway. Cell Cycle. 8(9). 1344–1351. 41 indexed citations
2.
Ravitz, Michael J., Li Chen, Mary C. Lynch, & Emmett V. Schmidt. (2007). c-myc Repression of TSC2 Contributes to Control of Translation Initiation and Myc-Induced Transformation. Cancer Research. 67(23). 11209–11217. 47 indexed citations
3.
Lynch, Mary C., Li Chen, Michael J. Ravitz, et al.. (2005). hnRNP K Binds a Core Polypyrimidine Element in the Eukaryotic Translation Initiation Factor 4E (eIF4E) Promoter, and Its Regulation of eIF4E Contributes to Neoplastic Transformation. Molecular and Cellular Biology. 25(15). 6436–6453. 100 indexed citations
4.
Ravitz, Michael J. & Charles E. Wenner. (1997). Cyclin-Dependent Kinase Regulation during G1 Phase and Cell Cycle Regulation by TGF-ß. Advances in cancer research. 71. 165–207. 121 indexed citations
5.
Ravitz, Michael J., et al.. (1996). Differential regulation of p27 and cyclin D1 by TGF-β and EGF in C3H 10T1/2 mouse fibroblasts. Journal of Cellular Physiology. 168(3). 510–520. 39 indexed citations
6.
Ravitz, Michael J., et al.. (1995). Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27Kip1 in C3H 10T1/2 mouse fibroblasts.. PubMed. 55(7). 1413–6. 40 indexed citations
7.
Kim, Tae‐Aug, Michael J. Ravitz, & Charles E. Wenner. (1994). Transforming growth factor‐β regulation of retinoblastoma gene product and E2F transcription factor during cell cycle progression in mouse fibroblasts. Journal of Cellular Physiology. 160(1). 1–9. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026